Cargando…

Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective

Half of the patients with ulcerative colitis require at least one course of systemic corticosteroids in their lifetime. Approximately 75% of these patients will also require immunosuppressive drugs (i.e., thiopurines or biological agents) in the mid-term to avoid colectomy. Immunosuppressive drugs r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domènech, Eugeni, Grífols, Joan-Ramon, Akbar, Ayesha, Dignass, Axel U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968132/ https://www.ncbi.nlm.nih.gov/pubmed/33776362 http://dx.doi.org/10.3748/wjg.v27.i10.908

Ejemplares similares

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results
por: Dignass, Axel, et al.
Publicado: (2016)

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
por: Dubinsky, Marla, et al.
Publicado: (2023)

Ulcerative Colitis: Shifting Sands
por: D’Haens, Geert R. A. M., et al.
Publicado: (2019)

Medical consultation in ulcerative colitis: Key elements for improvement
por: González-Lama, Yago, et al.
Publicado: (2023)

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries
por: Armuzzi, Alessandro, et al.
Publicado: (2023)

Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2023)

Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
por: Sernicola, Alvise, et al.
Publicado: (2022)

AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE)
Publicado: (2017)

Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
por: Jeon, Seong Ran
Publicado: (2017)

Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China
por: Lai, Ya-Min, et al.
Publicado: (2017)

Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
por: Yanagisawa, Kazuki, et al.
Publicado: (2019)

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)

Management of iron deficiency anemia in inflammatory bowel disease – a practical approach
por: Stein, Jürgen, et al.
Publicado: (2013)

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
por: Cheon, Jae Hee, et al.
Publicado: (2023)

Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
por: Nakamura, Masanao, et al.
Publicado: (2020)

Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain
por: de Carpi, Javier Martin
Publicado: (2022)

The Medical Community’s Role in Communication Strategies during Health Crises—Perspective from European Union of Medical Specialists (UEMS)
por: Nadareishvili, Ilia, et al.
Publicado: (2023)

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
por: Caron, Bénédicte, et al.
Publicado: (2023)

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone
por: Tominaga, Keiichi, et al.
Publicado: (2013)

Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2021)

Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2021)

Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives
por: Chen, Min, et al.
Publicado: (2023)

Letter to the Editor in response to the Position statement and best practice recommendations on the imaging use of ultrasound from the European Society of Radiology ultrasound subcommittee
por: Kalinka, Chris, et al.
Publicado: (2021)

Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective
por: Henning, Jan-Willem, et al.
Publicado: (2023)

Reply to the Letter to the editor in response to the Position statement and best practice recommendations on the imaging use of ultrasound from the European Society of Radiology ultrasound subcommittee
por: Brady, Adrian P., et al.
Publicado: (2021)

Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2020)

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
por: Koroku, Miki, et al.
Publicado: (2022)

Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2023)

The three-legged stool of evidence-based practice in eating disorder treatment: research, clinical, and patient perspectives
por: Peterson, Carol B., et al.
Publicado: (2016)

Can ‘Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,’ a subspecialty examination on glaucoma induce the qualification standard of glaucoma clinical practice in Europe?
por: Sunaric-Mégevand, Gordana, et al.
Publicado: (2016)

Gut Microbiota Crosstalk with Resident Macrophages and Their Role in Invasive Amebic Colitis and Giardiasis—Review
por: Xaplanteri, Panagiota, et al.
Publicado: (2023)

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
por: Danese, Silvio, et al.
Publicado: (2016)

Strategy required: “Maintenance of certification for European radiologists”
por: Karantanas, Apostolos H., et al.
Publicado: (2021)

Pulmonary function tests in ulcerative colitis
por: Amra, Babak, et al.
Publicado: (2014)

The Current State of Subjective Training Load Monitoring—a Practical Perspective and Call to Action
por: Coyne, Joseph O. C., et al.
Publicado: (2018)

Is blockchain the breakthrough we are looking for to facilitate genomic data sharing? The European Union perspective
por: Cascini, Fidelia, et al.
Publicado: (2022)

Privacy and Anonymity in the Information Society – Challenges for the European Union
por: Tsoukalas, Ioannis A., et al.
Publicado: (2011)

COVID-19: Situation of European Countries so Far
por: Pillai, Sunitha, et al.
Publicado: (2020)

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
por: Yokoyama, Yoko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ibi1rts2s4lh7mpbt65ggoaaa5